Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303)

[1]  Y. Tachimori,et al.  Comprehensive Registry of Esophageal Cancer in Japan, 2009 , 2016, Esophagus.

[2]  K. Hirakawa,et al.  Glasgow Prognostic Score as a Prognostic Clinical Marker in T4 Esophageal Squamous Cell Carcinoma. , 2015, Anticancer research.

[3]  T. Kawano,et al.  Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303) , 2015, Cancer science.

[4]  Y. Tachimori,et al.  Comprehensive Registry of Esophageal Cancer in Japan, 2008 , 2015, Esophagus.

[5]  Jun Zhang,et al.  Diagnostic Value of Multiple Tumor Markers for Patients with Esophageal Carcinoma , 2015, PloS one.

[6]  H. Yamaue,et al.  A new prognostic score for the survival of patients with esophageal squamous cell carcinoma , 2014, Surgery Today.

[7]  Wei Zhao,et al.  Prognostic significance of CYFRA21-1, CEA and hemoglobin in patients with esophageal squamous cancer undergoing concurrent chemoradiotherapy. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[8]  Baosheng Li,et al.  Predictors of sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma , 2010, Tumor Biology.

[9]  Soji Ozawa,et al.  Comprehensive Registry of Esophageal Cancer in Japan, 2002 , 2010, Esophagus.

[10]  D. McMillan.  Systemic inflammation, nutritional status and survival in patients with cancer , 2009, Current opinion in clinical nutrition and metabolic care.

[11]  D. McMillan,et al.  Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer , 2009, British Journal of Cancer.

[12]  Kaoru Kobayashi,et al.  Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma. , 2008, Surgery.

[13]  T. Yoshino,et al.  Impact of hemoglobin level on survival in definitive chemoradiotherapy for T4/M1 lymph node esophageal cancer. , 2008, Diseases of the esophagus.

[14]  D. Rades,et al.  The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation. , 2008, International journal of radiation oncology, biology, physics.

[15]  Hitoshi Nagata,et al.  Inflammation-Based Prognostic Score Is a Novel Predictor of Postoperative Outcome in Patients With Colorectal Cancer , 2007, Annals of surgery.

[16]  C. McArdle,et al.  Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer , 2007, International Journal of Colorectal Disease.

[17]  G. Jiang,et al.  Association of haemoglobin level with morbidity and mortality of patients with locally advanced oesophageal carcinoma undergoing radiotherapy--a secondary analysis of three consecutive clinical phase III trials. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).

[18]  Ross Carter,et al.  Evaluation of an Inflammation-Based Prognostic Score in Patients with Inoperable Pancreatic Cancer , 2006, Pancreatology.

[19]  D. McMillan,et al.  The relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer , 2006, Journal of Clinical Pathology.

[20]  D C McMillan,et al.  Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer , 2006, British Journal of Cancer.

[21]  D. McMillan,et al.  Evaluation of an inflammation‐based prognostic score in patients with metastatic renal cancer , 2006, Cancer.

[22]  J. Bartlett,et al.  Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer , 2006, British Journal of Cancer.

[23]  S. Yoshida,et al.  A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with T4 esophageal cancer: Japan Clinical Oncology Group trial (JCOG 9908) , 2005, Esophagus.

[24]  M. Shinoda,et al.  Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). , 2004, Japanese journal of clinical oncology.

[25]  C. McArdle,et al.  Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer , 2004, British Journal of Cancer.

[26]  T. Iwaya,et al.  Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs. , 2001, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[27]  T. Muto,et al.  Role of Esophagectomy in Treatment of Esophageal Carcinoma with Clinical Evidence of Adjacent Organ Invasion , 2001, World Journal of Surgery.

[28]  S. Yoshida,et al.  Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  M. Atkinson,et al.  Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. , 1982, Gut.

[30]  Qiang Zhao,et al.  Prognostic Significance of Glasgow Prognostic Score in Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma , 2014, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[31]  H. Gabra,et al.  Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer. , 2008, European journal of cancer.

[32]  Peter D Siersema,et al.  Esophageal cancer. , 2008, Gastroenterology clinics of North America.

[33]  J. Valencia Julve,et al.  Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy , 2006, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[34]  H. Fujita,et al.  Esophagectomy: Is It Necessary after Chemoradiotherapy for a Locally Advanced T4 Esophageal Cancer? Prospective Nonrandomized Trial Comparing Chemoradiotherapy with Surgery versus without Surgery , 2004, World Journal of Surgery.